Oral Oncology
Volume 38, Issue 6 , Pages 618-623 , September 2002

Expression of cell cycle proteins in head and neck cancer correlates with tumor site rather than tobacco use

  • S Haas

      Affiliations

    • Department of Otolaryngology, Head and Neck Surgery, University Hospital of Mannheim, D-68135 Germany
    • Corresponding Author InformationCorresponding author. Present address: Institute of Pathology, University of Bonn, Sigmund Freud Str. 25, D-53127 Bonn, Germany. Tel.: +49-228-287-5359; fax; +49-228-287-5030
    • ,
  • K Hörmann

      Affiliations

    • Department of Otolaryngology, Head and Neck Surgery, University Hospital of Mannheim, D-68135 Germany
    • ,
  • F.X Bosch

      Affiliations

    • Molecular Biology Laboratory, Department of Otolaryngology, Head and Neck Surgery, University of Heidelberg, D-69125 Germany

Received 25 July 2001 ,Accepted 6 August 2001.

References 

  1. Vokes EE, Weichselbaum R, Lippman S, Hong WK. Head and neck cancer (Review). N Engl J Med. 1993;328:184–194
  2. Koch WM, McQuone S. Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinker. Curr Op Oncol. 1997;9:257–261
  3. Tan EH, Adelstein DJ, Droughton ML, Van Kirk MA, Lavertu P. Squamous cell head and neck cancer in nonsmokers. Am J Clin Oncol. 1997;20:146–150
  4. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 1998;58:5–13
  5. Fouret P, Monceaux G, Temam S, Lacourreye L, StGuily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg. 1997;123:513–516
  6. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300–304
  7. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a cell cycle protein required for cellcycle progression in G1. Genes Dev. 1993;7(5–6):812–821
  8. Beijersbergen RL, Bernards R. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta. 1996;1287:103–120
  9. El-Deiry WS, Tokino T, Velescu VE, Levy DB, Parsons R, Trent JM, et al. WAF 1, a potenial mediator of p53 tumor suppression. Cell. 1993;75:817–825
  10. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, et al. Retinoblastoma-protein-dependent cell cycle inhibition by the tumor suppressor p16INK4a. Nature. 1995;375:503–506
  11. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope. 1999;109:1544–1551
  12. Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer. 1991;64:573–577
  13. Liloglou T, Scholes AG, Spandidos DA, Vaughan ED, Jones AS, Field JK. p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequence of genetic instability. Canc Res. 1997;57:4070–4074
  14. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332:712–717
  15. Lingen MW, Chang KW, McMurrray SJ, Solt DB, Kies MS, Mittal B, et al. Overexpression of p53 in squamous cell carcinoma of the tongue of young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck. 2000;22:328–335
  16. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol. 1999;1:20–26
  17. Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Oncogene. 2001;20:910–920
  18. Castle JT, Cardinali M, Kratochvil FJ, Abbondanzo SL, Kessler HP, Auclair PL, et al. p53 and Cyclin D1 staining patterns of malignant and premalignant oral lesions in age-dependent populations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:326–332
  19. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature. 1991;351:453–456
  20. Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, et al. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene. 1999;18:3541–3545
  21. Parry D, Bates S, Mann DJ, Peters G. Lack of Cyclin D/Cdk-complexes in Rb-negative cells correlates with high levels of p16INK4a INK4/MTS1 tumor suppressor gene product. EMBO J. 1995;14(3):503–511
  22. Boyer SN, Wazer DE, Band V. E7 protein of human papillomavirus 16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996;56:4620–4624
  23. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129–1136
  24. Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, Levine PA. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1993;119:1238–1243
  25. Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van Krieken JH. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell carcinoma. Anticancer Res. 1998;18:4793–4800
  26. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, et al. PRAD1-/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994;54:4813–4817
  27. Davidson BJ, Lydiatt WM, Abate MP, Schantz SP, Chaganti RS. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma. Head Neck. 1996;18:512–521
  28. Nogueira CP, Dolan RW, Gooey J, Byahatti S, Vaughan CW, Fuleihan NS, et al. Inactivation of p53 and amplification of Cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope. 1998;108:345–350
  29. Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCND1)/ cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer. 1994;74:152–158

PII: S1368-8375(01)00108-7

Oral Oncology
Volume 38, Issue 6 , Pages 618-623 , September 2002

Article Tools

* Image Usage & Resolution